Declaração PRISMA 2020
N.º 4 (2024), Artigos
N.º 4 (2024)

Declaração PRISMA 2020: uma diretriz atualizada para publicação de revisões sistemáticas

Artigos
https://doi.org/10.5281/zenodo.13271469
Publicado 2024-08-09 — Atualizado em 2024-08-09
Matthew Page
[1] 1School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Joanne McKenzie
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Patrick Bossuyt
Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands
Isabelle Boutron
Université de Paris, Centre of Epidemiology and Statistics (CRESS), Inserm, F 75004 Paris, France
Tammy Hoffmann
Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia
Cynthia Mulrow
University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA; Annals of Internal Medicine
Larissa Shamseer
Knowledge Translation Program, Li Ka Shing Knowledge Institute, Toronto, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada
Jennifer Tetzlaff
Evidence Partners, Ottawa, Canada
Elie Akl
Clinical Research Institute, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
Sue Brennan
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Roger Chou
Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA
Julie Glanville
York Health Economics Consortium (YHEC Ltd), University of York, York, UK
Jeremy Grimshaw
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada
Asbjørn Hróbjartsson
Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark
Manoj Lalu
Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada
Tianjing Li
Department of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Elizabeth Loder
Division of Headache, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; Head of Research, The BMJ, London, UK
Evan Mayo-Wilson
Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USA
Steve McDonald
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Luke McGuinness
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Lesley Stewart
Centre for Reviews and Dissemination, University of York, York, UK
James Thomas
EPPI-Centre, UCL Social Research Institute, University College London, London, UK
Andrea Tricco
Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada; Epidemiology Division of the Dalla Lana School of Public Health and the Institute of Health Management, Policy, and Evaluation, University of Toronto, Toronto, Canada; Queen’s Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen’s University, Kingston, Canada
Vivian Welch
Methods Centre, Bruyere Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada
Penny Whiting
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
David Moher
Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada
José Luís Sousa
INSIGHT - Piaget Research Center for Ecological Human Development, Portugal
Verónica Abreu
INSIGHT - Piaget Research Center for Ecological Human Development, Portugal
Verónica Oliveira
Sónia Gonçalves-Lopes
KinesioLab e RECI, Portugal

Arquivos suplementares

pdf

Palavras-chave

Diretriz de publicação
Revisão sistemática
Meta-análise
Escrita científica

Como Citar

Page, M., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., Mulrow , C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S., Chou, R., Glanville, J., Grimshaw, J., Hróbjartsson, A., Lalu, M., Li, T., Loder, E., Mayo-Wilson, E., McDonald, S., McGuinness, L., Stewart, L., Thomas, J., Tricco, A., Welch, V., Whiting, P., Moher, D., Sousa, J. L., Abreu, V., Oliveira, V. ., & Gonçalves-Lopes, S. (2024). Declaração PRISMA 2020: uma diretriz atualizada para publicação de revisões sistemáticas. Germinare — Revista Científica Do Instituto Piaget, (4), 1–19. https://doi.org/10.5281/zenodo.13271469
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Descarregar Citação

Endnote/Zotero/Mendeley (RIS) BibTeX

Resumo

A declaração PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), publicada em 2009, destina-se a ajudar os autores de revisões sistemáticas a relatar, de forma transparente, o motivo por que a revisão foi realizada, o que os autores fizeram e o que concluíram. Ao longo da última década, os avanços na terminologia e metodologia de elaboração de revisões sistemáticas exigiram uma atualização desta diretriz. A declaração PRISMA 2020 substitui a declaração de 2009 e inclui novas orientações que refletem os avanços nos métodos para identificar, selecionar, avaliar e sintetizar estudos. A estrutura e a apresentação dos itens foram modificadas para facilitar a implementação. Neste artigo, é apresentada a lista de verificação PRISMA 2020 de 27 itens, uma lista de verificação alargada que define as recomendações de publicação para cada item, a lista de verificação do resumo da PRISMA 2020 e os fluxogramas revistos para revisões originais e atualizadas.

Nota dos Editores Este artigo é a tradução portuguesa do PRISMA 2020 para revisões sistemáticas efetuada por Verónica Abreu, Sónia Gonçalves-Lopes, José Luís Sousa e Verónica Oliveira. 

https://doi.org/10.5281/zenodo.13271469
Creative Commons License

Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-CompartilhaIgual 4.0.

Direitos de Autor (c) 2024 Germinare — Revista Científica do Instituto Piaget